Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Rao, Xi; Chen, Yongmei; Beyrer, Julie; Nash Smyth, Emily; Morato Guimaraes, Claudia; Litchfield, Lacey M; Bowman, Lee; Lawrence, Garreth W; Aggarwal, Amit; Andre, Fabrice

Rao, Xi; Chen, Yongmei; Beyrer, Julie; Nash Smyth, Emily; Morato Guimaraes, Claudia; Litchfield, Lacey M; Bowman, Lee; Lawrence, Garreth W; Aggarwal, Amit; Andre, Fabrice.

Afiliación

Rao X; Eli Lilly and Company, Indianapolis, Indiana.
Chen Y; Eli Lilly and Company, Indianapolis, Indiana.
Beyrer J; Eli Lilly and Company, Indianapolis, Indiana.
Nash Smyth E; Eli Lilly and Company, Indianapolis, Indiana.
Morato Guimaraes C; Eli Lilly and Company, Indianapolis, Indiana.
Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana.
Bowman L; Eli Lilly and Company, Indianapolis, Indiana.
Lawrence GW; Eli Lilly and Company, Indianapolis, Indiana.
Aggarwal A; Eli Lilly and Company, Indianapolis, Indiana.
Andre F; Université Paris Sud, Orsay, France.

Clin Cancer Res ; 29(17): 3372-3383, 2023 09 01.

Article en En | MEDLINE | ID: mdl-37289194

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Quinasa 4 Dependiente de la Ciclina/genética; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/genética; Genes cdc; Genómica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google